AS is under 90 million and the float is lastly reported to be a miniscule 26 million. E was just removed, so they are current with the OTC and are expecting quarterly financials soon. After researching other stem cell stocks.. see STEM, I believe this one will be the next big runner in that sector.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.